Commitment to Positive Patient Outcomes
The Endo Health Outcomes & PharmacoEconomics (HOPE) department develops and communicates scientific information that demonstrates the value of our products to payers, providers, patients, and patients’ care givers. The HOPE team is composed of six field-based scientists and a headquarters-based scientific team of people with various backgrounds, from MDs to MBAs to PhDs. Most HOPE team members have 10+ years of diverse experience, including global pricing and reimbursement, patient-reported outcomes, clinical pharmacy management, and clinical account management. The results of this work support patient access to therapies, prescribing decisions, and compliance with prescribed therapies. They also have policy implications.